Home > Ancor Capital Partners acquires Healthtrak Rx
Buyout (LBO, MBO, MBI) · Life Science

Ancor Capital Partners acquires Healthtrak Rx

Ancor Capital Partners acquired Healthtrak Rx, a life science company in Texas, United States.

Deal at a glance

TypeBuyout (LBO, MBO, MBI) TargetHealthtrak Rx Buyer Ancor Capital Partners SectorLife Science LocationTexas, United States ValueNot disclosed

Target company

Healthtrak Rx
Texas, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Private equity firm · 36 deals on record
36deals, all time
2in this sector
2019latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Ollin Biosciences, Inc.Same sector and country · Nov 2026
OmnioseSame sector and country · Nov 2026
Orbus Therapeutics, Inc.Same sector and country · Oct 2026

Questions about this deal

Who acquired Healthtrak Rx?Ancor Capital Partners acquired Healthtrak Rx.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the life science sector.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).